跳至主要内容
临床试验/EUCTR2013-003125-28-GB
EUCTR2013-003125-28-GB进行中(未招募)1 期

Antiplatelet therapy for patients undergoing transcatheter aortic valve implantation - POPular-TAVI

St. Antonius Hospital0 个研究点目标入组 1,000 人开始时间: 2017年4月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patient has provided written informed consent.
  • 1.Need for long-term oral anticoagulation;
  • 2.Patient has provided written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1000

排除标准

  • 1.Need for long-term oral anticoagulation.
  • 2.Drug-eluting stent implantation within 3 months prior to TAVI procedure.
  • 3.Bare-metal stent implantation within 1 month prior to TAVI procedure.
  • 4.Allergy or intolerance or contraindication to aspirin or clopidogrel.
  • 1.Drug-eluting stent implantation within 3 months prior to TAVI procedure.
  • 2.Bare-metal stent implantation within 1 month prior to TAVI procedure.
  • 3.Use of non-vitamin K oral anticoagulation (NOAC).
  • 4.Allergy or intolerance or contraindication to OAC or clopidogrel.

研究者

相似试验